105176-70-3: Doxylamine Di-N-Oxide
Doxylamine is a H1 Antagonist. It is prescribed in a combination with pyridoxine for the treatment of nausea and vomitting.
Additional information on CAS 105176-70-3
N, N-Dimethyl-2-[1-phenyl-1-(2-pyridinyl)ethoxy]-ethanamine N, N’-dioxide
N, N-Dimethyl-2-[1-phenyl-1-(2-pyridinyl)ethoxy]-ethanamine N, N'-dioxide; N, ?N-?Dimethyl-?2-?[1-?(1-?oxido-?2-?pyridinyl)?-?1-?phenylethoxy]?-?ethanamine N-?oxide
"Friedman, H., et al. “Clearance of the Antihistamine Doxylamine.” Clinical Pharmacokinetics, vol. 16, no. 5, May 1989, pp. 312–16, https://doi.org/10.2165/00003088-198916050-00003. ?Koren, Gideon, et al. “Effectiveness of Delayed-Release Doxylamine and Pyridoxine for Nausea and Vomiting of Pregnancy: A Randomized Placebo Controlled Trial.” American Journal of Obstetrics and Gynecology, vol. 203, no. 6, Dec. 2010, pp. 571.e1–7, https://doi.org/10.1016/j.ajog.2010.07.030 "
Other products related to doxylamine
|CAS No.||Name of Impurity||Parent Drug||Catalogue No.|